Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 22, 2023

Clinical Implications and Treatment Strategies for ESR1 Fusions in Patients With HR+ Metastatic Breast Cancer

The Oncologist


Additional Info

The Oncologist
Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series
Oncologist 2023 Feb 08;28(2)172-179, JO Brett, LL Ritterhouse, ET Newman, KE Irwin, M Dawson, LY Ryan, LM Spring, MN Rivera, JK Lennerz, D Dias-Santagata, LW Ellisen, A Bardia, SA Wander

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading